Analysts gave the following ratings for Syros Pharmaceuticals SYRS for the past quarter:
|quickly||bit bullish||Moody||bit bearish||recession|
Cyros Pharmaceuticals has an average price target of $7.25, with a high of $10.00 and a low of $3.00, according to 4 analysts offering 12-month target prices in the last 3 months.
Below is a summary of how these 4 analysts rated Syros Pharmaceuticals over the last 3 months. The higher the number of bullish ratings, the more positive analysts rate the stock, and the higher the number of bearish ratings, the more negative analysts rate the stock.
It is down 39.58% from the current average price target of $12.00.
If you’re interested in following small-cap stock news and performance, you can start by following them here.
Ratings come from analysts or banking and financial systems experts who report for specific stocks or defined sectors (usually once a quarter for each stock). Analysts typically draw their information from company conference calls and meetings, financial statements, and interactions with key insiders to make their decisions.
Some analysts also provide predictions for helpful metrics like earnings, sales, and growth forecasts to provide further guidance on what to do with specific tickers. It’s important to note that stock and sector analysts are both experts and people and can only assess their beliefs for traders.
This article was created by Benzinga’s Automated Content Engine and is editor-reviewed.